Yun-Gyeong Bae
Chief Tech/Sci/R&D Officer bei APROGEN BIOLOGICS INC.
Vermögen: 119 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Yun-Gyeong Bae
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Unknown | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Yun-Gyeong Bae
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
YUHWA SECURITIES CO.,LTD. | Investment Banks/Brokers | Director/Board Member | |
APROGEN MEDICINES INC. | Pharmaceuticals: Major | Director/Board Member | |
Chung-Ang University | College/University | Graduate Degree | |
Kangwon National University | College/University | Undergraduate Degree | |
E&M Revolution Co., Ltd.
E&M Revolution Co., Ltd. Pharmaceuticals: MajorHealth Technology E & M Revolution Co., Ltd. is a South Korean company that manufactures pharmaceutical products. The CEO of the private company is Soon-Kyu Park. | Pharmaceuticals: Major | Director/Board Member | |
Aprogen Pharm, Inc.
Aprogen Pharm, Inc. Pharmaceuticals: MajorHealth Technology Aprogen Pharm, Inc. is a South Korean pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Hwaseong-si, South Korea. The CEO of the company is Jong-Su Gang. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
Südkorea | 10 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Operativ
Director/Board Member | 8 |
Chief Executive Officer | 3 |
Sales & Marketing | 2 |
Independent Dir/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jung-Chool Kim | 6 |
Min-Cheol Jeong | 3 |
Jong-Su Gang | 2 |
Dong-chul Shin | 2 |
Sung-Ho Kang | 1 |
- Börse
- Insiders
- Yun-Gyeong Bae
- Unternehmensverbindungen